AMA CPT® Assistant - 2024 Issue 11 (November)
Reporting mRNA Influenza Virus Vaccine Codes (November 2024)
November 2024 page 15 Reporting mRNA Influenza Virus Vaccine Codes For the CPT 2025 code set, two new Category I vaccine codes (90637, 90638) have been established to represent a new messenger (mRNA) influenza virus vaccine. This article provides an overview of the intent and appropriate use of these new codes. Note that the new mRNA influenza virus vaccine product codes will become effective upon receiving authorization from the United States Food and Drug Administration. Vaccines, Toxoids 90637Influenza virus vaccine, quadrivalent (qIRV), mRNA; 30 mcg/0.5 mL dosage, for intramuscular use 9063860 mcg/0.5 mL dosage, for intramuscular use...
Subscribe or sign in to view the full article.
Article Overview
This CPT Assistant article covers newly established Category I vaccine codes for an mRNA influenza virus vaccine in the CPT 2025 code set. It is relevant to coding professionals, billers, and clinical documentation staff who need to understand the scope of the new vaccine reporting guidance, the effective timing tied to FDA authorization, and the associated administration coding references discussed in the article.
Why This Topic Matters
The article helps readers identify when new vaccine reporting guidance applies and where to look for the related administration coding context. It is useful for staying current with CPT vaccine code changes affecting influenza immunization reporting.
Article Sections
-
Reporting mRNA Influenza Virus Vaccine Codes
Introduces the new CPT vaccine reporting topic and summarizes the purpose of the article. It also notes the timing of the new product codes in relation to regulatory authorization.
-
Vaccines, Toxoids
Presents the vaccine code listings discussed in the article and frames the discussion within the CPT vaccine section. The section supports the broader explanation of the new influenza vaccine reporting approach.
-
Clinical Example and Description of Procedure
Provides paired clinical scenarios and procedure narratives illustrating typical vaccine reporting contexts. The section is organized around the two new vaccine codes and their corresponding examples.
What You Will Learn
- What new CPT vaccine reporting topic is being introduced
- How the article frames the purpose and timing of the new vaccine codes
- What related administration coding references are discussed
- What kinds of clinical scenarios are used to illustrate the reporting context
Who Should Read This
- Medical coders
- Billing staff
- Clinical documentation specialists
- Compliance teams
- Healthcare administrators
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com